Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared on X:
“Personal selection of 30 new (+ new-ish) ADCs that will be presented at ASCO24 divided by payloads and targets.
Notes:
– Including ‘publication only’ abstracts,
– Not including mainstream ADCs and/or combo,
– Not including trial in progress.”
Source: Raffaele Colombo/X